Growth Metrics

Catheter Precision (VTAK) Cash from Financing Activities (2017 - 2025)

Catheter Precision (VTAK) has disclosed Cash from Financing Activities for 9 consecutive years, with $2.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Financing Activities fell 39.1% to $2.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $9.5 million, a 133.56% increase, with the full-year FY2024 number at $8.6 million, up 3.1% from a year prior.
  • Cash from Financing Activities was $2.4 million for Q3 2025 at Catheter Precision, down from $2.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $11.2 million in Q1 2022 to a low of -$516000.0 in Q2 2022.
  • A 5-year average of $3.4 million and a median of $2.6 million in 2025 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: crashed 114.47% in 2021, then skyrocketed 6956.44% in 2022.
  • Catheter Precision's Cash from Financing Activities stood at $141000.0 in 2021, then soared by 3592.2% to $5.2 million in 2022, then plummeted by 102.06% to -$107000.0 in 2023, then skyrocketed by 4276.64% to $4.5 million in 2024, then plummeted by 45.22% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Cash from Financing Activities are $2.4 million (Q3 2025), $2.7 million (Q2 2025), and -$75000.0 (Q1 2025).